Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer

NCT03545711 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Colo-rectal Cancer

Interventions

DRUG: Anlotinib Hydrochloride with Irinotecan

Sponsor

Chinese Academy of Medical Sciences